Viferaxs
ViferaXS is pioneering the forefront of immunotherapy with its revolutionary T cell activator platform, designed to harness the power of T cells in combating malignant diseases. By focusing on immunopeptidome-derived tumour antigens and employing an innovative adjuvant/formulation, XS15, the platform ensures precise targeting of naturally presented tumour antigens, enabling the direct killing of cancerous cells while activating and recruiting other immune components for a comprehensive response. We are interested in partnerships and funding discussions.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Viferaxs
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Viferaxs
1 distinct titles indexed · top 1 shown.
- 1consulting cmo to viferaxs
Sign up to unlock all 1 contacts at Viferaxs
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Viferaxs
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.